Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Cheap Stocks Under $50 to Buy Right Now

In this article, we will look at the 15 Cheap Stocks Under $50 to Buy Right Now.

On February 26, Ed Yardeni, Yardeni Research president, appeared on CNBC’s ‘Closing Bell’ to talk about his thoughts on the tech trade and the market’s standings. He stated that on December 7th, he rebalanced his recommendation on Mag7 and recommended underweighting them, thinking that there was going to be too much competition as a result of all of the money they were spending on data centers. He also went Overweight on going global instead of staying home. Those things, according to him, turned out pretty well, and there is still a way to go. For him, it is actually very healthy for the continuation of the bull market, but it is not a lot of fun for those who are still overweight by the Mag 7.

READ ALSO: 11 Cheap Blue Chip Stocks to Buy According to Analysts AND 10 Hot Stocks Under $20 to Buy

Yardeni was further of the opinion that the euphoria on AI was not sustainable, and turned into AI fatigue. Now, it has become AI fear, and is turning into almost an AI derangement syndrome, with people going off on the deep end about how this is going to result in major job losses and all sorts of other dire predictions. He himself considers them extreme reactions and believes AI to be a “great tool”, one that can be used to increase productivity. While he sees that as a positive, the market right now is going through all sorts of mental gymnastics.

With these broader market trends in view, let’s look at the best cheap stocks under $50 to buy right now.

Our Methodology

We sifted through the Finviz stock screener to compile a list of the best stocks under $50 with a forward P/E below 15. We then selected the top 15 stocks most popular among elite hedge funds as of Q3 2025, sourcing the hedge fund data from Insider Monkey’s database. The stocks are ranked in ascending order of hedge fund sentiment.

Note: All data was recorded on February 27.

​Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

15 Cheap Stocks Under $50 to Buy Right Now

15. Eni S.p.A. (NYSE:E)

Eni S.p.A. (NYSE:E) is one of the best cheap stocks under $50 to buy right now. RBC Capital lifted the price target on Eni S.p.A. (NYSE:E) to EUR 20 from EUR 17 on February 27, maintaining a Sector Perform rating on the shares. The firm told investors that the company has had consistent success with the drill bit over recent years, which has manifested through new JVs, increased divestment proceeds, and now production growth coming through.

Eni S.p.A. (NYSE:E) reported its fiscal Q4 and full-year 2025 results on February 26, reporting an adjusted net income of €1.20 billion in fiscal Q4, up 35% year-over-year. Fiscal Q4 CFFO came up to €3 billion, up 4% year-over-year. Management reported that cash flow remains well ahead of plan, with active portfolio management contributing to historically low gearing of 14%.

In its operational highlights, Eni S.p.A. (NYSE:E) also cited a binding agreement signed with Petronas to establish a jointly-controlled E&P satellite over Indonesia/Malaysia. Management stated that the agreement aims at combining two material gas asset portfolios with rich exploration potential and an initial production level of over 300 Kboe/d, anticipated to quickly ramp up to a sustainable level of over 500 Kboe/d.

Eni S.p.A. (NYSE:E) explores, refines, produces, and sells oil, electricity, gas, and chemicals. Its operations are divided into the following segments: Exploration and Production, Global Gas and LNG Portfolio, Refining & Marketing and Chemicals, Power & Renewables, and Corporate and Other Activities.

14. América Móvil (NYSE:AMX)

América Móvil (NYSE:AMX) is one of the best cheap stocks under $50 to buy right now. América Móvil (NYSE:AMX) was upgraded to Buy from Neutral by UBS on February 24, with the firm lifting the price target on the stock to $30 from $23.60 and telling investors that it sees upside to the current price and room for re-rating. It added that the company is seeing solid momentum across its main regions.

In a separate development, América Móvil (NYSE:AMX) reported fiscal Q4 2025 earnings on February 11, with the total revenue rising to MXN 245 billion and net profit quadrupling compared to the previous year. It added 2.5 million wireless subscribers during the quarter, bringing its total base to 331 million, and also exhibited notable strength in the high-value postpaid segment. Management further reported that the fixed-line broadband experienced over half a million new connections, supported by 92% of the company’s Mexican customer base now being on fiber-optic networks.

América Móvil (NYSE:AMX) provides telecommunications services, with its products and services including wireless data and value-added services, wireless voice, fixed data, fixed voice, broadband, and IT services, and more. The company’s operations are divided into the following segments: Mexico Wireless, Mexico Fixed, Brazil, Colombia, Southern Cone (Argentina, Chile, Paraguay and Uruguay), Andean Region (Ecuador and Peru), Central America (Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama), the Caribbean (the Dominican Republic and Puerto Rico) and Europe (Austria, Belarus, Bulgaria, Croatia, Macedonia, Serbia and Slovenia).

13. Banco Santander, S.A. (NYSE:SAN)

Banco Santander, S.A. (NYSE:SAN) is one of the best cheap stocks under $50 to buy right now. Morgan Stanley lifted the price target on Banco Santander, S.A. (NYSE:SAN) to EUR 12.10 from EUR 11.50 on February 26, maintaining an Equal Weight rating on the shares. Citi also raised the price target on Banco Santander, S.A. (NYSE:SAN) to EUR 12.50 from EUR 11.90 on February 24 and maintained a Buy rating on the shares.

In addition to Morgan Stanley and Citi, Banco Santander, S.A. (NYSE:SAN) received another bullish rating update from Deutsche Bank on February 23. The firm raised the price target on the stock to EUR 11.50 from EUR 9.80 and maintained a Buy rating on the shares.

The positive rating updates came after Banco Santander, S.A. (NYSE:SAN) delivered record full-year 2025 results, reporting an attributable profit of €14,101 million in 2025, up 12% year-on-year (or +16% in constant euros), with total customers reaching 180 million for the first time after adding eight million customers in the year. Management attributed the strong results to resilient net interest income, record fees, and efficiency gains, with continued improvement in credit quality.

Banco Santander (NYSE:SAN) is a Spain-based company that operates as a retail and commercial bank. Its segments are scattered across Continental Europe, the United Kingdom, Latin America, and the United States.

12. NatWest Group plc (NYSE:NWG)

NatWest Group plc (NYSE:NWG) is one of the best cheap stocks under $50 to buy right now. NatWest Group plc (NYSE:NWG) was upgraded to Neutral from Underperform by BNP Paribas on February 27, with the firm assigning a 670 GBp price target to the stock. In a separate development, NatWest Group plc (NYSE:NWG) announced on February 25 the launch of a new range of protection insurance to its retail and mortgage customers, offering a fast and intuitive digital experience, allowing homebuyers to obtain quotes and apply for vital protection cover.

The new product suite encompasses Life Insurance, expanded Critical Illness Cover, and Over 50s Life Insurance, helping expand eligibility and access to protection. NatWest Group plc (NYSE:NWG) reported significant enhancements in Critical Illness Cover, now providing protection for 52 conditions.

Separately, NatWest Group plc (NYSE:NWG) announced annual results for 2025 on February 13, reporting that it increased its customer base by around a million customers, grew its profit before tax to £7.7 billion, and delivered a Return on Tangible Equity (RoTE) of 19.2%. Management stated that strong capital generation and distributions came from increased profitability and disciplined balance sheet and risk management.

NatWest Group plc (NYSE:NWG) provides international banking and financial services. The company’s operations are divided into the following segments: Retail Banking, Private Banking, Commercial and Institutional, and Central Items and Other.

11. Equinor ASA (NYSE:EQNR)

Equinor ASA (NYSE:EQNR) is one of the best cheap stocks under $50 to buy right now. On February 25, JPMorgan lifted the price target on Equinor ASA (NYSE:EQNR) to NOK 240 from NOK 220 and reaffirmed an Underweight rating on the shares. In a separate development, Equinor ASA (NYSE:EQNR) and Eneco announced on February 5 the signing of a 5-year agreement for deliveries of gas to Eneco, with the volumes up to 0.5 billion cubic meters (bcm) per year, and deliveries to the Dutch gas grid from 1 February this year. Eneco is a main supplier of natural gas, electricity, and heat in the Netherlands.

Management reported that the agreement concerns gas with a lower-than-average greenhouse gas footprint due to the production and transport of gas on the Norwegian continental shelf having a smaller greenhouse gas footprint than other sources of gas supplied to Europe. Equinor ASA (NYSE:EQNR) further reported that, in addition to the supply of gas, it will transfer guarantees of origin, named ‘sustainability qualities’, to Eneco through a platform operated by provider Attributes SAS. Eneco stated the agreement would lower its CO2 emissions by more than 10%.

​Equinor ASA (NYSE:EQNR) explores, transports, produces, refines, and markets petroleum and petroleum-derived products. The company’s operations are divided into the following segments: Exploration and Production Norway, Exploration and Production International, Exploration and Production USA, Marketing, Midstream, and Processing, Renewables, and Other.

10. Enterprise Products Partners (NYSE:EPD)

Enterprise Products Partners (NYSE:EPD) is one of the best cheap stocks under $50 to buy right now. Enterprise Products Partners (NYSE:EPD) received several bullish rating updates from analysts in February following the release of its yearly results. On February 5, Scotiabank raised the price target on Enterprise Products Partners (NYSE:EPD) to $37 from $35 while maintaining a Sector Perform rating on the shares. The firm told investors that while the quarter was solid and the guidance is currently beating consensus expectations, there exists a gap between communicated data points and the end result in a model.

Enterprise Products Partners (NYSE:EPD) also received a rating update from TD Cowen on February 4, with the firm lifting the price target on the stock to $34 from $33 and maintaining a Hold rating on the shares. The firm stated that it updated its model after quarterly results as the company lifted its 2027 outlook. The same day, RBC Capital also raised the price target on Enterprise Products Partners (NYSE:EPD) to $40 from $35 and maintained an Outperform rating on the shares. It contended that projects coming online are anticipated to drive strong free cash flows and solid 2027 growth, driving increased capital returns to investors through mid-single digit distribution growth and accelerated unit buybacks.

Enterprise Products Partners (NYSE:EPD) is involved in the production and trade of natural gas and petrochemicals. The company’s operations are divided into the following segments: NGL Pipelines and Services, Crude Oil Pipelines and Services, Natural Gas Pipelines and Services, and Petrochemical and Refined Products Services.

9. Sanofi (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) is one of the best cheap stocks under $50 to buy right now. On February 27, Sanofi (NASDAQ:SNY) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending the approval of Dupixent in the EU to treat chronic spontaneous urticaria. Management reported that the recommendation covers children aged two to 11 years with moderate-to-severe CSU, an inadequate response to histamine-1 antihistamines, and who are naïve to anti-immunoglobulin E therapy for CSU. A final decision is anticipated in the coming months.

Sanofi (NASDAQ:SNY) further reported that data from the LIBERTY-CUPID clinical study program support the positive CHMP opinion in young children, including two phase 3 studies in which children aged six to 11 years participated, and the single-arm, CUPIDKids phase 3 study in children aged two to 11 years with CSU. Dupixent holds approval for CSU in certain adults and adolescents in several jurisdictions, including Japan, the EU, and the US. In addition, a supplemental biologics license application has been accepted for review in the United States, seeking approval for Dupixent in certain children aged two to 11 years with CSU, with a decision by the US Food and Drug Administration expected by April 2026.

Sanofi (NASDAQ:SNY) researches, produces, and distributes pharmaceutical products. The company’s operations are divided into the Pharmaceuticals, Consumer Healthcare, and Vaccines segments.

8. UBS Group AG (NYSE:UBS)

UBS Group AG (NYSE:UBS) is one of the best cheap stocks under $50 to buy right now. UBS Group AG (NYSE:UBS) announced changes to its Board of Directors on February 27, reporting the nomination of Agustín Carstens and Luca Maestri for election to the Board at the Annual General Meeting on 15 April 2026. William C. Dudley and Jeanette Wong have decided not to stand for re-election.

Separately, UBS Group AG (NYSE:UBS) has received several rating updates following the release of its fiscal Q4 and full year 2025 results on February 4, in which it reported net profit of $1.2 billion in fiscal Q4 2025, up 56% YoY, and $7.8 billion in fiscal year 2025, up 53%. The company also announced an increase in dividend by 22% year-over-year, confirmed its targets for 2026, and set ambitions for 2028 with ~18% return on CET1 capital and ~67% cost/income ratio for the group, driven primarily by further sustainable growth and efficiency gains across its business divisions.

Following the earnings release, UBS Group AG (NYSE:UBS) was downgraded to Neutral from Buy by Goldman Sachs on February 6, with the firm bringing the price target on the stock down to CHF 38 from CHF 41.50. Citi also cut the price target on the stock to CHF 35.40 from CHF 37.70 on February 5 and maintained a Neutral rating on the shares.

UBS Group AG (NYSE:UBS) provides financial management solutions, with the company’s operations divided into the following segments: Global Wealth Management, Personal and Corporate Banking, Asset Management, Investment Bank, Non-Core and Legacy, and Group Items.

7. Kinross Gold Corporation (NYSE:KGC)

Kinross Gold Corporation (NYSE:KGC) is one of the best cheap stocks under $50 to buy right now. On February 26, BofA lifted the price target on Kinross Gold Corporation (NYSE:KGC) to $42.75 from $37.50 while reiterating a Buy rating on the shares and telling investors that it is updating its price targets for the North American Metals & Mining stocks under its coverage after updating forecasts for metal prices in 2026.

The rating update came after Kinross Gold Corporation (NYSE:KGC) announced its fiscal Q4 and full year 2025 results on February 18, reporting that it delivered on all key guidance metrics and maintains a three-year outlook of 2.0 million Au eq. oz. per year. It reported a record free cash flow of $2.5 billion and returned $1.5 billion to debt and equity holders in 2025. The company is also targeting 40% of free cash flow in return on capital to shareholders in 2026.

Kinross Gold Corporation (NYSE:KGC) also provided operational highlights for the period, stating that Tasiast was the highest-margin operation in the portfolio and Paracatu produced over 600,000 gold ounces, marking the eighth consecutive year over 500,000 Au oz. Operating cash flow for the quarter was $1.146 billion, and $3.760 billion for the full year 2025.

Based in Canada, Kinross Gold Corporation (NYSE:KGC) is a global senior gold mining company that operates in the US, Brazil, Mauritania, Chile, and Canada. Its projects include Fort Knox, Round Mountain, Bald Mountain, Manh Choh, Paracatu, La Coipa, Lobo-Marte, Tasiast, and Great Bear projects.

6. Keurig Dr. Pepper Inc. (NASDAQ:KDP)

Keurig Dr. Pepper Inc. (NASDAQ:KDP) is one of the best cheap stocks under $50 to buy right now. Wells Fargo lifted the price target on Keurig Dr. Pepper Inc. (NASDAQ:KDP) to $40 from $35 on February 25, maintaining an Overweight rating on the shares and noting that shares were up 4.2%, closing at the highest levels since the JDEP acquisition was announced in August. The firm further stated that in a backdrop featuring higher estimates and a Staples tape where value is harder to find, it wonders if Keurig Dr. Pepper Inc. (NASDAQ:KDP) will intrigue a bit more.

The rating update came after Keurig Dr. Pepper Inc. (NASDAQ:KDP) announced its fiscal Q4 and full year 2025 results on February 24, reporting that it delivered 2025 results consistent with guidance, with performance led by solid momentum in U.S. refreshment beverages. Its full-year 2025 highlights showed a constant currency net sales growth of more than 8%, driven primarily by U.S. Refreshment Beverages and International segments. Net sales for fiscal Q4 rose 10.5% to $4.5 billion, and on a constant currency basis, net sales advanced 9.9%, attributed to favorable net price realization of 6.0% and volume/mix growth of 3.9%. Keurig Dr. Pepper Inc. (NASDAQ:KDP) stated that the acquisition of GHOST contributed 3.6 percentage points to volume/mix growth.

Keurig Dr. Pepper Inc. (NASDAQ:KDP) is involved in the manufacture, distribution, marketing, and sale of non-alcoholic beverages. Its operations are divided into the following segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment distributes and manufactures beverage concentrates, syrups, and finished beverages, including the brands Dr. Pepper, Snapple, A&W, 7UP, Hawaiian Punch, Core Hydration, Bai, Yoo-Hoo, Vita Coco, and more.

5. Vale S.A. (NYSE:VALE)

Vale S.A. (NYSE:VALE) is one of the best cheap stocks under $50 to buy right now. Vale S.A. (NYSE:VALE) was downgraded to Neutral from Buy by BofA on February 26, with the firm adjusting the price target on the stock to $18 from $17. It told investors in a research note that it sees a “mismatch” with the shares up 35% year-to-date while iron ore prices are down 7%, adding that it expects limited upside in the shares from here, given the decline in iron ore prices and declines in steel demand. According to the firm, the stock is already priced in Vale’s (NYSE:VALE) near-term potential.

In another development, Freedom Capital lifted the price target on Vale S.A. (NYSE:VALE) to $14.10 from $12 on February 20 and maintained a Hold rating on the shares. The firm told investors that it anticipates copper prices to continue to trend higher, with a demand for refined copper supported by long-term structural drivers.

The rating updates came after Vale S.A. (NYSE:VALE) announced its performance in fiscal Q4 and full year 2025 on February 12, reporting strong operational and cost performance across all business segments, with all 2025 guidances achieved. The company reported robust sales, with iron ore, copper, and nickel sales growing by 5%, 8%, and 5% year-over-year in fiscal Q4 2025, respectively, and up 3%, 12%, and 11% in 2025, respectively.

Vale S.A. (NYSE:VALE) is a global mining and metals company that is based in Rio de Janeiro, Brazil, and has a presence in over 20 countries. It is the world’s largest producer of iron ore and nickel, and it also has operations in manganese, ferroalloys, copper, gold, silver, and cobalt.

4. Brookfield Corporation (NYSE:BN)

Brookfield Corporation (NYSE:BN) is one of the best cheap stocks under $50 to buy right now. Morgan Stanley lifted the price target on Brookfield Corporation (NYSE:BN) to $60 from $58 on February 17 and maintained an Overweight rating on the shares. Scotiabank also raised the price target on Brookfield Corporation (NYSE:BN) to $52 from $49 on February 13, reaffirming an Outperform rating on the shares.

The rating updates followed Brookfield Corporation’s (NYSE:BN) release of financial results for the year ended December 31, 2025, on February 12, 2026. Total consolidated net income reached $1.7 billion for the quarter and $3.2 billion for the year, while distributable earnings before realizations were $1.5 billion ($0.63/share) for the quarter and $5.4 billion ($2.27/share) for the year.

Management reported that Brookfield Corporation’s (NYSE:BN) strong 2025 financial results were supported by the company’s asset management business recording $112 billion of inflows, the continued growth of its wealth solutions business, and its operating businesses generating resilient and growing cash flows.

Brookfield Corporation (NYSE:BN) manages public and private investment products and services. The company’s operations are divided into the following business segments: Asset Management, Renewable Power and Transition, Infrastructure, Private Equity, Real Estate and Other Alternatives.

3. BP p.l.c. (NYSE:BP)

BP p.l.c. (NYSE:BP) is one of the best cheap stocks under $50 to buy right now. BP p.l.c. (NYSE:BP) was downgraded to Neutral from Outperform by Grupo Santander on February 26, with the firm setting a price target of 520 GBp. BP p.l.c. (NYSE:BP) also received a rating update from JPMorgan on February 25, with the firm lifting the price target on the stock to 500 GBp from 470 GBp and maintaining a Neutral rating on the shares.

In another update, BP p.l.c. (NYSE:BP) was downgraded to Sell from Hold by Freedom Capital on February 12. The firm kept the price target unchanged at $37, and told investors that it views the company’s fiscal Q4 results as soft, with BP p.l.c. (NYSE:BP) even suspending its share repurchase program amid weaker oil prices. According to the firm, further oil market weakness in 2026 could weigh “materially” on BP’s earnings. The same day, HSBC also downgraded BP p.l.c. (NYSE:BP) to Reduce from Hold, adjusting the price target to $35.10 from $38.10. The firm believes that while the company is making the right strategic moves, the payoff is “years away”.

Headquartered in London, United Kingdom, BP p.l.c. (NYSE:BP) is an integrated oil and gas company that provides carbon products and services. Its operations are divided into the Gas and Low Carbon Energy, Oil Production and Operations, and Customers and Products segments.

2. Novo Nordisk A/S (NYSE:NVO)

Novo Nordisk A/S (NYSE:NVO) is one of the best cheap stocks under $50 to buy right now. Novo Nordisk A/S (NYSE:NVO) announced on February 27 that the US Food and Drug Administration approved three new indications for once-weekly Sogroya injection 5 mg, 10 mg, or 15 mg, a long-acting growth hormone, for children aged at least 2.5 years with Idiopathic Short Stature (ISS), short stature born Small for Gestational Age without catch-up growth by the age of 2 years, and growth failure associated with Noonan Syndrome.

The approval marks the first long-acting growth hormone supporting children with these three indications in the United States. Somapacitan-beco also holds approval for children aged at least 2.5 years with growth hormone deficiency. Since the option is once-weekly, it helps children and caregivers struggling with daily injections for hormone treatment.

In another development, Novo Nordisk A/S (NYSE:NVO) and Vivtex Corporation announced on February 25 a partnership for the development of next-generation oral biologic medicines for obesity, diabetes, and associated comorbidities. According to the terms of the agreement, Vivtex would license select oral drug-delivery technologies to Novo Nordisk A/S (NYSE:NVO), with Vivtex eligible to receive upfront consideration, research funding, and milestone payments totalling up to $2.1 billion, and tiered royalties on future product sales.

Novo Nordisk A/S (NYSE:NVO) is a global healthcare company specializing in diabetes care. It develops, discovers, manufactures, and markets pharmaceutical products. Its operations are divided into two business segments: biopharmaceuticals and diabetes and obesity care. The latter segment covers GLP-1, insulin, and other protein-related products.

1. Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy right now. Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. announced on February 27 positive results from the Phase 3 EV-304 clinical trial for PADCEVTM, a Nectin-4 directed antibody-drug conjugate, in combination with Keytruda®, a PD-1 inhibitor, in patients with muscle-invasive bladder cancer eligible for cisplatin-based chemotherapy.

Management reported that Perioperative (before and after surgery) enfortumab vedotin plus pembrolizumab exhibited a 47% drop in the risk of tumor recurrence, progression, or death compared to patients treated with standard of care neoadjuvant (before surgery) gemcitabine and cisplatin. It further reported that an estimated 79.4% of patients were event-free at two years, relative to 66.2% treated with standard of care neoadjuvant chemotherapy.

In a separate development, Pfizer Inc. (NYSE:PFE) was initiated with an Underperform rating and a $25 price target by RBC Capital on February 24, with the firm stating that it reflects an “insurmountable” $15B-$20B revenue cliff through 2030 with little near-term pipeline visibility seen to offset it. It further stated that although a 6% dividend yield offers downside support above the peer average, it cannot offset structural headwinds and the lack of 2026 catalysts.

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that manufactures, develops, markets, and sells biopharmaceutical products worldwide. It advances wellness, prevention, treatment, and cures in developing and emerging markets, and is also involved in developing immunotherapies that help the immune system to recognise and attack cancer cells.

While we acknowledge the potential of PFE to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PFE and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.